GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Stock Based Compensation

Beijing Strong Biotechnologies (SZSE:300406) Stock Based Compensation : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Stock Based Compensation?

Beijing Strong Biotechnologies's Stock Based Compensation for the three months ended in Mar. 2024 was ¥0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.


Beijing Strong Biotechnologies Stock Based Compensation Historical Data

The historical data trend for Beijing Strong Biotechnologies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Stock Based Compensation Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Beijing Strong Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Beijing Strong Biotechnologies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.


Beijing Strong Biotechnologies Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies (SZSE:300406) Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines